Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference on Friday, October 31, 2014, at 2:30 p.m. EDT (1:30 p.m. CDT) to review data presented at the Chicago Multidisciplinary Symposium on Thoracic Oncology (CMSTO) in Chicago. Company executives will provide an overview of data presented at the meeting, with a focus on the company’s immuno-oncology portfolio, and address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at: http://investor.bms.com or by dialing 647-788-4901, conference code: 19907013. Materials related to the call will be available at the same website prior to the call. A replay of the call will be available beginning at 3:30 p.m. EDT on October 31, 2014 through 1:59 EST on November 11, 2014. The replay can be accessed at http://investor.bms.com or by dialing 404-537-3406, confirmation code: 19907013.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

Bristol-Myers Squibb CompanyMedia:Laura Hortas, 609-252-4587laura.hortas@bms.comorInvestors:John Elicker, 609-252-4611john.elicker@bms.comorRanya Dajani, 609-252-5330ranya.dajani@bms.comorRyan Asay, 609-252-5020ryan.asay@bms.com

Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bristol Myers Squibb Charts.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bristol Myers Squibb Charts.